Biofilm Infection Therapeutics

End-to-end testing for antibiotic adjuvants, anti-biofilm device coatings, and advanced dressings.

Therapeutic Modalities We Support

Robust biofilm models spanning planktonic-to-mature states, mono- and polymicrobial challenges, and clinically relevant surfaces.

Synergy testing (checkerboard, time-kill, MBEC) to quantify potency boosts and resistance suppression.

Anti-biofilm surface evaluations on metals, polymers, meshes, and catheters with durability and re-growth checks.

Antimicrobial and anti-biofilm dressing assessments on relevant substrates with repeat dosing regimens.

Mechanistic readouts paired with decision-ready potency metrics.

MBEC / MBIC, time-kill kinetics, and CFU/luminescent viability curves

Microscopy-based biomass and architecture (CLSM/SEM options)

Re-growth / persistence assessments post-treatment

Resistance development and post-exposure susceptibility profiling

Surface adhesion, coating durability, and fouling resistance

Cytotoxicity and hemocompatibility panels on request

Iterative, data-first collaboration from screening through preclinical validation.

Define target organisms, materials, dosing ranges, and comparator controls.

Execute standardized and custom anti-biofilm protocols with QA checkpoints.

Generate quantitative potency metrics plus imaging-backed mechanistic insights.

Iterate with formulation tweaks, dosing cadence, or material refinements.

Actionable data package with methods, raw data, and next-step recommendations.

Share your target organisms, materials, and success criteria—we will propose the fastest, most informative path forward.

Name *

Email *

Service of Interest *